Statistical Consulting
Designing Effective Clinical Trials
Strategic consulting is a key component of our biostatistics service offering and is frequently a pathway for initiating new client relationships by demonstrating the value that SDC adds to your clinical program in this area. From supporting your efforts in designing the most effective and efficient trials for your clinical program to representing you at regulatory meetings with FDA or other regulatory agencies, our statistical consultants are with you every step of the way.
- Clinical Program Development
- Clinical Trial Design
- Protocol Development
- Sample Size Calculations
- Interim Analysis and DMC Planning
- Risk-Based Monitoring Plan Development
- Regulatory Meeting Representation (Pre-IND/IDE through Submission)
- Ad-Hoc Statistical Analyses
- Investor or Board Meeting Support
- Manuscript Development
Renowned experts Ken Getz (Tufts Center for the Study of Drug Development), Joe Massaro (Boston University), and Dale Usner (SDC) discuss Adaptive Clinical Trial Designs at SDC’s Grand Opening celebration in Waltham, Mass.